Trillium Therapeutics Inc. (TRIL.TO) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Mississauga, ON, Canada. The current CEO is Jan Skvarka.
TRIL.TO has IPO date of 2014-04-22, 33 full-time employees, listed on the Toronto Stock Exchan.
No company description available.
